Who Gets Chemotherapy for HIV-associated Lymphoma?

news_18_Artboard 343 copy 211

Learn more about how autologous hematopoietic cell transplant (AHTC) are recommended as standard of care in patients with HIV-Related Lymphoma after high-doses of chemotherapy.

Chemotherapy has been shown to increase the survival rate of patients with HIV-associated lymphomas.

But recently, new data has revealed that not all patients are equally likely to receive chemotherapy, according to researchers at the Alpert Medical School of Brown University.

Learn more about those being affected here.

Lymphoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Leave a Comment

Your email address will not be published. Required fields are marked *